ASSESSING THE IMPLEMENTABILITY OF REGULATORY AGENCIES' GUIDANCE ON DIVERSITY IN CLINICAL TRIALS

被引：0
|
作者：
Metcalfe, R. [1 ]
Reshef, S. [2 ]
Park, J. [1 ]
机构：
[1] Core Clin Sci, Vancouver, BC, Canada
[2] Teva Branded Pharmaceut Prod R&D Inc, Epidemiol & Global Hlth Econ & Outcomes Res, Parsippany, NJ USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR87
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [41] Regulatory issues in ALS clinical trials
    Bryan, WW
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2004, 5 : 36 - 41
  • [42] Clinical trials site recruitment optimisation: Guidance from Clinical Trials: Impact and Quality
    Zahren, Christine
    Harvey, Sonia
    Weekes, Leanne
    Bradshaw, Charlotte
    Butala, Radhika
    Andrews, John
    O'Callaghan, Sally
    CLINICAL TRIALS, 2021, 18 (05) : 594 - 605
  • [43] Assessing the Implementability of Clinical Pharmacist Interventions in Patients With Chronic Kidney Disease: An Analysis of Systematic Reviews
    Salgado, Teresa M.
    Correr, Cassyano J.
    Moles, Rebekah
    Benrimoj, Shalom I.
    Fernandez-Llimos, Fernando
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1498 - 1506
  • [44] Diversity in probiotics and diversity in clinical trials: Opportunities for improvement
    Marcelin, Jasmine R.
    Fadul, Nada
    Cawcutt, Kelly A.
    Abdul-Mutakabbir, Jacinda C.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (10): : 1508 - 1509
  • [45] FDA Guidance for ABSSSI Trials: Implications for Conducting and Interpreting Clinical Trials
    Itani, Kamal M. F.
    Shorr, Andrew F.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 : S4 - S9
  • [46] Assessing DNA Repairs in Clinical Trials
    Hong, Ted
    ONCOLOGIST, 2017, 22 : S1 - S1
  • [47] Assessing abuse liability in clinical trials
    Brady, KT
    Lydiard, RB
    Brady, JV
    DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (03) : S87 - S95
  • [48] Assessing Usual Care in Clinical Trials
    Erlen, Judith A.
    Tamres, Lisa K.
    Reynolds, Nancy
    Golin, Carol E.
    Rosen, Marc I.
    Remien, Robert H.
    Banderas, Julie W.
    Schneiderman, Neil
    Wagner, Glenn
    Bangsberg, David R.
    Liu, Honghu
    WESTERN JOURNAL OF NURSING RESEARCH, 2015, 37 (03) : 288 - 298
  • [49] Assessing adverse reactions in clinical trials
    Harnisch, S.
    Schade-Brittinger, C.
    Rief, W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (27) : 1421 - 1425
  • [50] Assessing quality of life in clinical trials
    Epstein, RS
    EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 67 - 76
12345